STM publisher Elsevier, Netherlands, has released a special issue of the journal Antiviral Research, marking the 25th anniversary of antiretroviral drug development.
Guest edited by José Esté from Hospital Germans Trias i Pujol, Barcelona, Spain, and Tomas Cihlar, from Gilead sciences Inc., CA, US, the special issue features a variety of review articles from key players in the field. Introducing this special issue of Antiviral Research, Samuel Broder from the Celera Corporation in Alameda, describes how in the last 25 years, HIV-1 has gone from being an ‘inherently untreatable’ infectious agent to one eminently susceptible to a range of approved therapies. In the late 1980s his group, then at the National Cancer Institute, played a key role in the discovery and development of the first generation of antiretroviral agents.
In 2010, Antiviral Research will celebrate its 30th anniversary by organising an Antivirals Congress from November 7-9, 2010, in Amsterdam. The guest editors and various authors of this special issue will present at the Congress, which is expected to serve as an interface between academics, those in research and development, regulatory and governmental agencies, charities, and health and industry professionals.
Search for more infectious diseases related books/journals
